Rhenman & Partners Asset Management’s Dermira, Inc. DERM Stock Holding History

Rhenman & Partners Asset Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-800,000	Closed	-$12.1M	–	97
2019 Q4	$12.1M	Buy	800,000 +250,700	+46%	+$2.16M	1.33%	32
2019 Q3	$3.51M	Buy	549,300 +48,971	+10%	+$409K	0.44%	64
2019 Q2	$4.78M	Hold	500,329	–	–	0.53%	60
2019 Q1	$6.78M	Buy	+500,329	New	+$4.17M	0.79%	52
2018 Q2	–	Sell	-95,000	Closed	-$759K	–	94
2018 Q1	$759K	Hold	95,000	–	–	0.09%	74
2017 Q4	$2.64M	Sell	95,000 -5,000	-5%	-$133K	0.36%	69
2017 Q3	$2.7M	Buy	+100,000	New	+$2.62M	0.34%	72

Rhenman & Partners Asset Management's DERM Position: Q1 2020 in Review

Rhenman & Partners Asset Management sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 800,000 shares — an estimated $12.1M sold.

Rhenman & Partners Asset Management first reported a position in DERM in Q3 2017 and held it in 7 quarters. The position peaked at $12.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Rhenman & Partners Asset Management reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Rhenman & Partners Asset Management sold 800,000 Dermira, Inc. shares in Q1 2020, an estimated $12.1M.
Rhenman & Partners Asset Management first reported a position in Dermira, Inc. in Q3 2017 and held it in 7 quarters.
Rhenman & Partners Asset Management's Dermira, Inc. position peaked at $12.1M in Q4 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2020, filed 16 Apr 2020.